Related Experiment Videos
Smokeless tobacco: an emerging addiction
Jon O Ebbert1, Alan B Carr, Lowell C Dale
1Department of Medicine, Mayo Clinic College of Medicine, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA. ebbert.jon@mayo.edu
The Medical Clinics of North America
|October 7, 2004
Summary
Smokeless tobacco (ST) use poses significant health risks, including nicotine dependence and withdrawal symptoms. Understanding ST
Area of Science:
- Public Health
- Pharmacology
- Clinical Medicine
Background:
- Smokeless tobacco (ST) use is a major public health concern in the U.S.
- Chronic ST use results in considerable morbidity and mortality.
- ST users exhibit nicotine dependence and withdrawal symptoms similar to smokers.
Purpose of the Study:
- To provide a comprehensive review of smokeless tobacco.
- To inform clinical treatment strategies for ST users.
- To cover ST products, epidemiology, pharmacology, health risks, and treatment.
Main Methods:
- Literature review of existing research on smokeless tobacco.
- Synthesis of data on ST products and their characteristics.
- Analysis of epidemiological trends and health consequences.
- Review of pharmacological properties and addiction potential.
- Examination of current treatment modalities.
Main Results:
- ST products deliver substantial nicotine levels, comparable to cigarettes.
- Nicotine withdrawal symptoms are prevalent in individuals attempting to cease ST use.
- ST use is associated with various adverse health outcomes.
- Effective treatment requires tailored approaches considering ST's unique properties.
Conclusions:
- Addressing smokeless tobacco use necessitates a thorough understanding of its multifaceted aspects.
- Clinical interventions must be adapted to the specific challenges posed by ST addiction.
- Further research into ST's long-term health impacts and optimized cessation strategies is warranted.